Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | OT |
Customer reported a 32-year-old female patient received one dose of GARDASIL 9 in 2019 and has not received additional doses since. No symptoms reported. No other information available at time of report. Caller consented to correspondence. No add; Noadditional AE/No PQC reported; This spontaneous report was received from a Pharmacist and refers to a(n) 32-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date in 2019, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), 0.5 mL (0.5ML), administered by Unknown route (lot # and expiration date were not reported), as Prophylaxis, and had not received additional doses since. No symptoms or adverse events reported. Lot # is being requested and will be submitted if received.